Australian pharmacists raise concerns over proforma letters provided by AbbVie

Oct 9, 2021

The Australian reported that Australian pharmacists have raised concerns over proforma letters provided by AbbVie to prescribing doctors (specialist rheumatologists and gastroenterologists) and public hospital clinics instructing chemists to only dispense Humira® branded adalimumab rather than biosimilar adalimumab.

Print Page Mail Article